Professional Documents
Culture Documents
Medicinal Chemistry
Medicinal Chemistry
Medicinal Chemistry
_______________1. The practice of medicinal chemistry that is devoted to the discovery and
development of new drugs.
_________________2. An agent intended for use in the diagnosis, mitigation,
treatment, cure, or prevention of disease in humans or in other animals.
________________3.A substance to which a drug needs to interact with to elicit a
pharmacological response. 90% proteins, some are nucleic acids and lipids
________________4.RECEPTOR AS DRUG TARGET._____&______
________________5.Ability of drug to bind to the receptor.
________________6.Ability of a drug to exert a pharmacologic action.
________________7.What are the 4 drug targets interactions.
________________8.Affinity + Intrinsic activity
________________9.Affinity only
________________10.3Types Of Antagonist
________________11.Binds to a receptor but does not activate it
________________12.Effects opposite that of the agonist by binding to a different receptor
________________13.Does not use a receptor
_______________14.Drug showing both agonist and antagonist activities
________________15.Receptors have active and inactive forms
________________16.Site other than the binding sit
________________17.It is determined by measuring the maximum possible effect
. resulting from receptor-ligand binding.
________________18.Relates how effective a drug is in producing a cellular effect.
________________19.it is a situation where increase doses of a drug are required over time to
achieve same effect
________________20.Compulsion to take the drug repeatedly and experiences unpleasant
symptoms if discontinued.
________________21.Study how drug interacts with their target to produce a pharmacologic
effect.What drugs do to the body
________________22. What the body does to the drug./It includes absorption, distribution,
metabolism, and excretion. (ADME)
________________23.FOUR FUNDAMENTAL PATHWAYS OF DRUG PHARMACOKINETICS
________________24.the transfer of a drug from its site of administration to the systemic
circulation (or to the bloodstream)
________________25.100% crystalline (long-acting)
________________26.70% crystalline, 30% amorphous (intermediate)
________________27.100% amorphous (short-acting)
________________28. aka Biotransformation/the fraction of administered drug that reaches
the systemic circulation in a chemically unchanged form
________________29.the process by which a drug reversibly leaves the bloodstream and
enters the interstitium (extracellular fluid) and/or the cells of the tissues
________________30serves as a reservoir Albumin - binds acidic drugs α-1-acid
glycoprotein - binds basic drugs/ may limit access to certain body
compartments/Prolongs drug duration of action
________________31.converts drugs into polar form, water-soluble products that are readily
excretable/detoxification process but not all the time
________________32.This is a GENERAL PATHWAY OF DRUG METABOLISM Phase 1
(Functionalization) (3 types)
________________33. This is a GENERAL PATHWAY OF DRUG METABOLISM Phase 2
(Conjugation) (4 types)
________________34. Reactions resulting in the addition of oxygen and/or the removal of
hydrogen.CYP3A4 - most dominant form of CYP450 in liver
________________35.Reactions resulting in the addition of hydrogen and/or the removal of
oxygen
________________36. Drug containing ester/a bond in the compound is broken, resulting in
two compounds.
________________37. most common phase II reaction
________________38. well developed in infant
________________39.important for drugs containing primary amino group
________________40.It is common among catecholamines
________________41.compounds that are inactive in their native form, but are easily
metabolized to the active agent
________________42. the main route of excretion of a drug and its metabolite is through the
kidney (for LMW & polar drugs)/ Other types: Biliary/Fecal, Breastmilk,
Sweat (for HMW & lipophilic drugs)
________________43.drugs emptied via the bile duct into the small intestine can be
reabsorbed in the intestinal lumen back to systemic circulation
________________44.L.A.D.M.E stands for
________________45.5 MODES OF DRUG TRANSPORT
________________46. Process by which molecules spontaneously diffuse from a region of
high concentration to a region of lower concentration.
________________47. aka Pore Transport
________________48. Describes the movement of transport of large ions.